Approval · Notice of Compliance 7097 · 2005
NOROXIN: Notice of Compliance 7097
Issued June 17, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7097
- Date
- June 17, 2005
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antibacterial agent
Products in this notice
Medicinal ingredients
- NORFLOXACIN 3 MG per ML
- NORFLOXACIN 400 MG per TAB